Trial intelligence / Profile preview

Liposomal Paclitaxel with Nedaplatin in Advanced Esophageal Carcinoma

NCT02861690Phase 2Completed

Sponsor
Sun Yat-sen University
Start
Jan 2010
Primary completion
Sep 2015
Modality
Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
Countries
1
01

Overview

A Phase 2 trial of liposomal paclitaxel in esophageal carcinoma, sponsored by Sun Yat-sen University. Started Jan 2010; status: completed.

02

Drugs

liposomal paclitaxel
03

Conditions

esophageal carcinoma

Beyond the preview

Go deeper on NCT02861690.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02861690.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call